245 filings
Page 4 of 13
8-K
un4xae0v6lejpkit59
15 Apr 22
LIXTE Biotechnology Announces $5.8 Million Registered Direct Offering Priced At-The-Market
12:00am
424B5
6inzdpcl5ga5kfbe2sz9
14 Apr 22
Prospectus supplement for primary offering
6:15am
8-K
7ki596p1rm2gi6 hdin8
23 Mar 22
Other Events
12:54pm
8-K
rx36i2y 7smn8a9zq1i8
13 Oct 21
Entry into a Material Definitive Agreement
10:01am
424B5
i17eb
20 Sep 21
Prospectus supplement for primary offering
5:22pm
8-K
8plvym47 osxyxzbya
20 Sep 21
Entry into a Material Definitive Agreement
5:21pm
8-K
n3igjkq47dr5t26x
9 Jul 21
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
79txm1k8bf7uk w7co
3 Jun 21
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer
3:21pm
DEFA14A
i7uuew jso
25 May 21
Additional proxy soliciting materials
12:00am
DEF 14A
vbgjukxa
25 May 21
Definitive proxy
12:00am
8-K
65nvs2g
14 May 21
Lixte Biotechnology Holdings, Inc. Announces the Appointment of Regina Brown to Its Board of Directors
2:42pm
PRE 14A
wol9dp
13 May 21
Preliminary proxy
2:12pm
S-8
a9r1hria rafp6fe9dj
21 Apr 21
Registration of securities for employees
4:06pm
8-K
hhbje40j
13 Apr 21
Lixte Biotechnology Holdings, Inc. Announces the Appointment of Gil N Schwartzberg to its Board of Directors
4:52pm
8-K
kxms1t a7
2 Mar 21
VI.Lixte Biotechnology Announces $4.19 Million Registered Direct Offering
4:55pm